You are viewing: UK Bioresorbable Polymers Market analysis
Part of: Bioresorbable Polymers Market (Global)

The UK Bioresorbable Polymers Market was valued at $17.3 Million in 2024 and projected to reach to $29.6 Million by 2029, representing a compound annual growth rate of 11.4%. The UK bioresorbable polymers market is positioned for sustained growth through 2029, driven by increasing adoption in orthopedic implants, cardiovascular devices, and tissue engineering applications.

UK Bioresorbable Polymers Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Bioresorbable Polymers Market Trends and Insights

  • The UK market is driven by increasing demand from the medical device and pharmaceutical sectors, where bioresorbable polymers are essential for temporary implants, drug delivery systems, and tissue engineering applications.
  • The UK's strong healthcare infrastructure and regulatory framework support innovation in biodegradable material technologies. The UK bioresorbable polymers market benefits from rising investment in advanced manufacturing and R&D capabilities across the country.
  • UK-based companies and research institutions are actively developing next-generation bioresorbable solutions to meet stringent regulatory standards and clinical requirements.
  • The UK's position within Europe and its commitment to sustainable materials further accelerate market penetration across medical and industrial applications through 2029..

Key Market Statistics

  • CAGR (2024-2029) 11.4% CAGR
  • Market Size, 2024 ~USD 17.3 Million
  • Forecast, 2029 ~USD 29.6 Million
  • Country UK

UK Bioresorbable Polymers Market Overview

Market Valuation Growth :

The UK bioresorbable polymers market is valued at $17.3 million in 2024, with a projected CAGR of 11.4%, reaching $29.6 million by 2029, demonstrating strong double-digit expansion.

Medical Device Dominance :

UK medical device manufacturers are increasingly adopting bioresorbable polymers for temporary implants and surgical applications, driven by NHS procurement standards and regulatory compliance requirements.

Pharmaceutical & Drug Delivery :

UK pharmaceutical companies are leveraging bioresorbable polymers for controlled-release drug delivery systems, supported by growing R&D investments and clinical trial activities across major research institutions.

Healthcare Infrastructure Support :

The UK's advanced healthcare system, including leading academic medical centers and NHS backing, creates a favorable environment for bioresorbable polymer innovation and commercialization.

UK Bioresorbable Polymers Market Dynamics

  • NHS initiatives promoting advanced medical technologies and the UK's post-Brexit focus on domestic innovation are accelerating market expansion.
  • Regulatory support from the MHRA and growing collaboration between UK biotech firms and medical device manufacturers are expected to drive product development and market penetration.
  • The sector benefits from strong intellectual property protections and substantial government funding for life sciences research, positioning the UK as a key hub for bioresorbable polymer innovation in Europe..

Related Ecosystem

Green Bio Chemicals

Top Technologies
  • Animal-Based Sealants
  • Bacterial Fermentation
  • Corrosion Inhibitors
  • Hydrogen Peroxide
  • Nitrile Butadiene Rubber (NBR)
Top Companies
  • Basf se
  • Evonik industries ag
  • Solvay sa
  • AZELIS HOLDINGS SA
  • CARGILL, INCORPORATED

    Resins And Polymers

    Top Technologies
    • Polycarbonate
    • Acrylonitrile Butadiene Styrene (ABS)
    • Epoxy Resin
    • Light Commercial Vehicles (LCVs)
    • Polypropylene (PP)
    Top Companies
    • Basf se
    • DOW CHEMICAL COMPANY
    • Solvay sa
    • Saudi arabia basic industries corporation (sabic)
    • DuPont de Nemours, Inc.

      Key Takeaways

      • The UK bioresorbable polymers market is valued at $17.3 million in 2024 and will reach $29.6 million by 2029, representing a 11.4% CAGR.
      • The UK market is primarily driven by demand from medical device manufacturers and pharmaceutical companies requiring biocompatible, temporary implant solutions.
      • The UK's advanced healthcare infrastructure and regulatory environment position it as a key hub for bioresorbable polymer innovation and commercialization.
      • Sustainability initiatives and R&D investments across the UK are accelerating adoption of bioresorbable materials in clinical and industrial applications.

      Bioresorbable Polymers Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment PLGA (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 11.6% from 2024 to 2029
      Largest Segment ORTHOPEDIC DEVICES (Application)
      Market Size Base Year (Billions) ~USD 0.5 (2024)
      Revenue Forecast (Billions) ~USD 0.87 (2029)
      Segments Covered Type, Application

      UK Bioresorbable Polymers Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Type

      • Other Types
      • Pcl
      • Pga
      • Pla
      • Plga
      • -Pdlla
      • -Plla

      By Application

      • Drug Delivery
      • Hip
      • Knee
      • Oral
      • Orthopedic Devices
      • Other Applications
      • Other Drug Delivery Applications
      • Other Orthopedic Device Applications
      • Parenteral
      • Spine
      • Sports Injury
      • Trauma

      UK: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029

      Segment2023202420252026202720282029CAGR (%)
      DRUG DELIVERY5.996.67.328.169.1610.311.611.9
      ORTHOPEDIC DEVICES8.69.4110.3511.4612.7514.2315.9111.1
      OTHER APPLICATIONS1.131.241.371.521.691.892.1211.3
      TOTAL15.7317.2519.0521.1423.626.4229.6311.4

      Target Audience

      • Medical Device Manufacturers : UK-based and international device makers need market intelligence to identify bioresorbable polymer applications, assess competitive positioning, and plan product development aligned with NHS requirements.
      • Pharmaceutical Companies : Pharma firms developing controlled-release formulations and drug delivery systems require UK market data to evaluate bioresorbable polymer adoption rates and commercialization opportunities.
      • Investment & Private Equity Firms : Investors targeting UK life sciences and biotech sectors need market sizing and growth forecasts to evaluate investment opportunities in bioresorbable polymer manufacturers and innovators.
      • Healthcare Procurement Officers : NHS trusts and hospital procurement teams require market analysis to understand bioresorbable polymer availability, supplier options, and cost-benefit assessments for medical device acquisitions.
      • Research & Academic Institutions : UK universities and research centers developing bioresorbable polymer technologies need market data to validate commercialization potential and identify collaboration or licensing opportunities.

      Reasons to Buy this Report

      • UK-Specific Market Sizing : Obtain precise market valuation data for the UK bioresorbable polymers sector with accurate 2024 baseline ($17.3M) and 2029 forecasts ($29.6M), enabling targeted investment and expansion decisions.
      • Regulatory & Compliance Insights : Understand UK-specific regulatory pathways through MHRA, NHS procurement requirements, and post-Brexit compliance standards essential for market entry and product commercialization strategies.
      • Competitive Landscape Analysis : Identify key UK-based manufacturers, distributors, and emerging players in the bioresorbable polymers space, including partnership opportunities and competitive positioning within the domestic market.
      • Sector-Specific Growth Drivers : Analyze UK demand patterns across medical devices, pharmaceuticals, and tissue engineering applications, with insights into NHS adoption rates and healthcare provider procurement trends.
      • Strategic Market Entry Planning : Develop informed go-to-market strategies for the UK with data on regional demand hotspots, key stakeholder networks, and growth opportunities aligned with the 11.4% CAGR trajectory.

      Frequently asked questions

      What is the current size of the UK bioresorbable polymers market?

      The UK bioresorbable polymers market was valued at $17.3 million in 2024 and is expected to grow to $29.6 million by 2029.

      What is the projected growth rate for the UK bioresorbable polymers market?

      The UK bioresorbable polymers market is projected to grow at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2029.

      Which industries drive demand for bioresorbable polymers in the UK?

      The UK medical device, pharmaceutical, and tissue engineering sectors are the primary drivers of bioresorbable polymer demand, particularly for temporary implants and drug delivery systems.

      Why is the UK a significant market for bioresorbable polymers?

      The UK's advanced healthcare infrastructure, strong regulatory framework, and substantial R&D investments make it a leading market for bioresorbable polymer innovation and adoption.

      What factors are expected to accelerate UK market growth through 2029?

      Sustainability initiatives, increased clinical applications, regulatory support, and growing investment in advanced manufacturing capabilities are expected to drive UK market expansion through 2029.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the market size for bioresorbable polymers market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

      Secondary Research

      Secondary sources used in this study included annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles from recognized authors; and gold standard & silver standard websites such as Factiva, ICIS, Bloomberg, and others. The findings of this study were verified through primary research by conducting extensive interviews with key officials such as CEOs, VPs, directors, and other executives. The breakdown of profiles of the primary interviewees is illustrated in the figure below:

      Primary Research

      The bioresorbable polymers market comprises several stakeholders, such as raw material suppliers, end-product manufacturers, and regulatory organizations in the supply chain. The demand side of this market is characterized from key opinion leaders in various applications for the bioresorbable polymers market. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

      The following is a breakdown of the primary respondents:

      Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022/ 2023, available in the public domain, product portfolios, and geographical presence.

      Other designations include consultants and sales, marketing, and procurement managers.

      To know about the assumptions considered for the study, download the pdf brochure

      COMPANY NAME DESIGNATION
      Evonik Industries AG Sales Manager
      Ashland Global Holdings Inc. R&D Manager
      KLS Martin Group Global R&D Head
      DSM Biomedical Business Development Manager
      Poly-Med Incorporated Regional Sales Manager

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioresorbable polymers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry have been identified through extensive secondary research.
      • The supply chain of the industry has been determined through primary and secondary research.
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
      • All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.

      Data Triangulation

      After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioresorbable polymers industry.

      Market Definition

      The bioresorbable polymers are the type of polymers. They are designed to naturally degrade and be absorbed within biological environments. These polymers are utilized in medical and healthcare sectors, where they are used to manufacture orthopedic devices and drug delivery systems. The demand of bioresorbable polymers influenced by the innovation in medical devices and the need for the eco-friendly alternatives to the permanent implants. The key components of the bioresorbable polymers are PLA, PGA, PLGA, and PCL.

      Stakeholders

      • Bioresorbable polymers manufacturers
      • Bioresorbable polymers suppliers
      • Raw material suppliers
      • Application sector companies
      • Government bodies

      Report Objectives

      • To define, describe, and forecast the bioresorbable polymers market in terms of value and volume
      • To provide detailed information regarding the drivers, opportunities, restraints, and challenges influencing market growth
      • To estimate and forecast the market size by type, application, and region
      • To forecast the size of the market for five main regions: Asia Pacific, Europe, North America, South America, and the Middle East & Africa, along with their key countries
      • To strategically analyze micromarkets1 with respect to their growth trends, prospects, and contribution to the overall market
      • To analyze opportunities in the market for stakeholders and provide a competitive landscape for market leaders
      • To analyze competitive developments, such as deals and expansions, in the market
      • To strategically profile key players and comprehensively analyze their growth strategies

      Get the Full Bioresorbable Polymers Market Report

      Full forecast, segment splits, and company analysis for all Bioresorbable Polymers Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status